Quarterly report · Q2

Period2021-04-01 → 2021-09-30
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed

Amends S100MTSB.

Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.2bn2021-04-01 → 2021-09-30Cons.Net sales
Revenue¥3.9bn2020-04-01 → 2021-03-31Cons.Net sales (5-year summary)
Revenue¥2.2bn2020-04-01 → 2020-09-30Cons.Net sales
Operating income¥132m2021-04-01 → 2021-09-30Cons.Operating income
Operating income¥105m2020-04-01 → 2020-09-30Cons.Operating income
Ordinary income¥144m2021-04-01 → 2021-09-30Cons.Ordinary income
Ordinary income¥46m2020-04-01 → 2021-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥236m2020-04-01 → 2020-09-30Cons.Ordinary income
Profit before tax¥140m2021-04-01 → 2021-09-30Cons.Income before income taxes
Profit before tax−¥243m2020-04-01 → 2020-09-30Cons.Income before income taxes
Net income (owners)¥110m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥255m2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥281m2020-04-01 → 2020-09-30Cons.Profit loss attributable to owners of parent
Net income¥110m2021-04-01 → 2021-09-30Cons.Profit loss
Net income−¥281m2020-04-01 → 2020-09-30Cons.Profit loss
Total assets¥8.5bnat 2021-09-30Cons.Assets
Total assets¥8.3bnat 2021-03-31Cons.Assets
Total assets¥9.1bnat 2020-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2021-09-30Cons.Liabilities
Total liabilities¥962mat 2021-03-31Cons.Liabilities
Net assets / equity¥7.5bnat 2021-09-30Cons.Net assets
Net assets / equity¥7.3bnat 2021-03-31Cons.Net assets
Net assets / equity¥3.4bnat 2020-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.1bnat 2021-09-30Cons.Cash and deposits
Cash and deposits¥2.1bnat 2021-03-31Cons.Cash and deposits
Cash & equivalents¥2.1bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2020-09-30Cons.Cash and cash equivalents
Cash & equivalents¥945mat 2020-03-31dCons.Cash and cash equivalents
Operating cash flow¥250m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2020-04-01 → 2020-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥6m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥695m2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥320m2020-04-01 → 2020-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥213m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.2bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2020-04-01 → 2020-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥12.22021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.742021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-38.822020-04-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-50.662020-04-01 → 2020-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252020-07-01 → 2020-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥12.192021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio87.3%at 2021-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.5%at 2021-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.3%at 2020-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 31
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥208m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥921m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥921m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥246m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥237m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥237m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥94m
—segment totalrevenue2021-04-01 → 2021-09-30¥1.2bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.2bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥341m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥341m
Reconciling Itemsreconcilingrevenue2020-04-01 → 2020-09-30−¥5m
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2020-09-30−¥5m
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2020-09-30−¥235m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2020-04-01 → 2020-09-30¥724m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2020-04-01 → 2020-09-30¥724m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2020-04-01 → 2020-09-30¥190m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2020-04-01 → 2020-09-30¥1.5bn
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2020-04-01 → 2020-09-30¥1.5bn
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue intersegment2020-04-01 → 2020-09-30¥5m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2020-04-01 → 2020-09-30¥150m
—segment totalrevenue2020-04-01 → 2020-09-30¥2.2bn
—segment totalrevenue external2020-04-01 → 2020-09-30¥2.2bn
—segment totalrevenue intersegment2020-04-01 → 2020-09-30¥5m
—segment totalsegment profit2020-04-01 → 2020-09-30¥340m
Total Of Reportable Segments And Otherssegment totalrevenue2020-04-01 → 2020-09-30¥2.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-04-01 → 2020-09-30¥2.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-04-01 → 2020-09-30¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2020-04-01 → 2020-09-30¥340m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 560
ItemContextValueUnit
Other selling expenses sgaPrior1YTDDuration82000000JPY
Other selling expenses sgaCurrentYTDDuration111000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember724000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember1479000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember2204000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2204000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration2204000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-5000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember724000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember1485000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember2209000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2209000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-5000000JPY
Net salesPrior1YTDDuration2204000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember190000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember150000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember340000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember340000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-235000000JPY
Operating incomePrior1YTDDuration105000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember921000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember237000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember1158000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1158000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration1158000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember921000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember237000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember1158000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1158000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-JPY
Net salesCurrentYTDDuration1158000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember246000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember94000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember341000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember341000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-208000000JPY
Operating incomeCurrentYTDDuration132000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2021-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2020-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2020-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2020-04-01/2020-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2021-09-30pass